387 related articles for article (PubMed ID: 24534393)
21. RANKL, denosumab, and giant cell tumor of bone.
Thomas DM
Curr Opin Oncol; 2012 Jul; 24(4):397-403. PubMed ID: 22581354
[TBL] [Abstract][Full Text] [Related]
22. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
Rutkowski P; Gaston L; Borkowska A; Stacchiotti S; Gelderblom H; Baldi GG; Palmerini E; Casali P; Gronchi A; Parry M; Campanacci DA; Scoccianti G; Wagrodzki M; Ferrari S; Dijkstra S; Pieńkowski A; Grimer R
Eur J Surg Oncol; 2018 Sep; 44(9):1384-1390. PubMed ID: 29650420
[TBL] [Abstract][Full Text] [Related]
23. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
Deveci MA; Paydaş S; Gönlüşen G; Özkan C; Biçer ÖS; Tekin M
Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623
[TBL] [Abstract][Full Text] [Related]
24. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
Roitman PD; Jauk F; Farfalli GL; Albergo JI; Aponte-Tinao LA
Hum Pathol; 2017 May; 63():89-97. PubMed ID: 28235628
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone.
Lau CP; Huang L; Wong KC; Kumta SM
Connect Tissue Res; 2013; 54(6):439-49. PubMed ID: 24060052
[TBL] [Abstract][Full Text] [Related]
26. Giant cell tumour of bone in the denosumab era.
van der Heijden L; Dijkstra PDS; Blay JY; Gelderblom H
Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529
[TBL] [Abstract][Full Text] [Related]
27. Can Denosumab cure giant cell tumors of the spine? A case report and literature review.
Xará-Leite F; Coutinho L; Fleming C; Magalhães M; Oliveira V; Rodrigues-Pinto R; Cardoso P
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):19-23. PubMed ID: 31529151
[TBL] [Abstract][Full Text] [Related]
28. Preoperative Cytoreduction of Clival Giant Cell Tumor: An Effective Replication of the Systemic Modality in the Skull Base.
Sekar A; Rudrappa S; Gopal S; Ghosal N; Gupta V; Ts L
World Neurosurg; 2018 Nov; 119():97-102. PubMed ID: 30075260
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of Osteosclerotic Change Following Treatment with an Antibody Against RANKL for Giant Cell Tumour of the Bone.
Rosario M; Takeuchi A; Yamamoto N; Hayashi K; Miwa S; Higuchi T; Abe K; Taniguchi Y; Aiba H; Tanzawa Y; Murakami H; Tsuchiya H
Anticancer Res; 2017 Feb; 37(2):749-754. PubMed ID: 28179326
[TBL] [Abstract][Full Text] [Related]
30. A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With Denosumab.
Aponte-Tinao LA; Piuzzi NS; Roitman P; Farfalli GL
Clin Orthop Relat Res; 2015 Sep; 473(9):3050-5. PubMed ID: 25758379
[TBL] [Abstract][Full Text] [Related]
31. Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report.
Watanabe N; Matsumoto S; Shimoji T; Ae K; Tanizawa T; Gokita T; Motoi N; Ueno T; Koizumi M
BMC Res Notes; 2014 Sep; 7():608. PubMed ID: 25193435
[TBL] [Abstract][Full Text] [Related]
32. Vertebral compression fractures in patients under treatment with denosumab: a contraindication for percutaneous vertebroplasty?
Mattei TA; Mendel E; Bourekas EC
Spine J; 2014 Jun; 14(6):e29-35. PubMed ID: 24316116
[TBL] [Abstract][Full Text] [Related]
33. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report.
Goto Y; Furuno Y; Kawabe T; Ohwada K; Tatsuzawa K; Sasajima H; Hashimoto N
J Neurosurg; 2017 Feb; 126(2):431-434. PubMed ID: 27177173
[TBL] [Abstract][Full Text] [Related]
34. Spondylectomy for Giant Cell Tumor After Denosumab Therapy.
de Carvalho Cavalcante RA; Silva Marques RA; dos Santos VG; Sabino E; Fraga AC; Zaccariotti VA; Arruda JB; Fernandes YB
Spine (Phila Pa 1976); 2016 Feb; 41(3):E178-82. PubMed ID: 26579960
[TBL] [Abstract][Full Text] [Related]
35. Giant cell tumor of the sacrum and spine: series of 23 cases and a review of the literature.
Martin C; McCarthy EF
Iowa Orthop J; 2010; 30():69-75. PubMed ID: 21045974
[TBL] [Abstract][Full Text] [Related]
36. Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum.
Bukata SV; Blay JY; Rutkowski P; Skubitz K; Henshaw R; Seeger L; Dai T; Jandial D; Chawla S
Spine (Phila Pa 1976); 2021 Mar; 46(5):277-284. PubMed ID: 33038190
[TBL] [Abstract][Full Text] [Related]
37. Giant Cell Tumor of Cervical Spine Presenting as Acute Asphyxia: Successful Surgical Resection After Down-Staging With Denosumab.
Kumar R; Meis JM; Amini B; McEnery KW; Madewell JE; Rhines LD; Benjamin RS
Spine (Phila Pa 1976); 2017 May; 42(10):E629-E632. PubMed ID: 27792106
[TBL] [Abstract][Full Text] [Related]
38. Denosumab salvage therapy in an 11-year-old boy with locally recurrent unresectable giant cell tumor of the lumbar spine after surgery.
Luo Y; Xiu P; Chen H; Zeng J; Song Y; Li T
Neurochirurgie; 2023 May; 69(3):101427. PubMed ID: 36828057
[TBL] [Abstract][Full Text] [Related]
39. Effect of denosumab on recurrent giant cell reparative granuloma of the lumbar spine.
Akeda K; Kasai Y; Sakakibara T; Matsumine A; Takegami N; Yamada J; Sudo A
Spine (Phila Pa 1976); 2015 May; 40(10):E601-8. PubMed ID: 25955096
[TBL] [Abstract][Full Text] [Related]
40. Giant cell tumor of the cervical spine treated by carbon ion radiotherapy: A case report.
Sakuda T; Furuta T; Okimoto T; Adachi N
Medicine (Baltimore); 2021 Oct; 100(41):e27393. PubMed ID: 34731109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]